Controlled clinical trial of cannabidiol in Huntington's disease
- 7 November 1991
- journal article
- clinical trial
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 40 (3), 701-708
- https://doi.org/10.1016/0091-3057(91)90386-g
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Huntington's disease: Correlations of mental status with choreaBiological Psychiatry, 1987
- Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administrationJournal of Mass Spectrometry, 1986
- Open label evaluation of cannabidiol in dystonic movement disordersInternational Journal of Neuroscience, 1986
- Selective reminding test: An examination of the equivalence of four formsJournal of Clinical and Experimental Neuropsychology, 1985
- Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Quantitative measurement of Δ9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometryJournal of Mass Spectrometry, 1983
- Single dose kinetics of deuterium labelled Δ1-tetrahydrocannabinol in heavy and light cannabis usersJournal of Mass Spectrometry, 1982
- Interactions ofΔ 11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographyCellular and Molecular Life Sciences, 1981
- Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic PatientsPharmacology, 1980
- A comparison of the pharmacological activity in man of intravenously administered 1368-11368-11368-1, cannabinol, and cannabidiolCellular and Molecular Life Sciences, 1973